Home/Filings/4/0001567619-19-018368
4//SEC Filing

Mantripragada Sankaram 4

Accession 0001567619-19-018368

CIK 0001509261other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:14 PM ET

Size

5.9 KB

Accession

0001567619-19-018368

Insider Transaction Report

Form 4
Period: 2019-07-31
Mantripragada Sankaram
Chief Scientific Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2019-07-31+3,500,0003,500,000 total
    Exercise: $0.29Exp: 2029-07-31Common Stock (3,500,000 underlying)
Footnotes (1)
  • [F1]587,500 of the options is fully exercisable as of the date of grant. Vesting of 1,762,500 options will occur in thirty-six equal installments beginning on the first day of each month thereafter, such grant vested in full after 3 years. The remaining 1,150,000 options vest equally over a 36-month period following certain performance and market price criteria. Such remaining options will not necessarily vest or convert into non-derivative securities to be beneficially owned by the Reporting Person.

Documents

1 file

Issuer

Rezolute, Inc.

CIK 0001509261

Entity typeother

Related Parties

1
  • filerCIK 0001405632

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:14 PM ET
Size
5.9 KB